- Home
- HUIZ vs XLO Comparison
HUIZ vs XLO Comparison
Compare HUIZ & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | XLO |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 41.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | XLO |
|---|---|---|
| Price | $3.55 | $0.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $2.30 | $2.00 |
| AVG Volume (30 Days) | 4.0K | ★ 522.5K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $186,519,166.00 | $31,804,000.00 |
| Revenue This Year | $22.67 | $589.60 |
| Revenue Next Year | $8.55 | $38.00 |
| P/E Ratio | $14.22 | ★ N/A |
| Revenue Growth | 19.12 | ★ 588.40 |
| 52 Week Low | $1.50 | $0.62 |
| 52 Week High | $4.53 | $1.70 |
Technical Indicators
Market Signals| Indicator | HUIZ | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 54.33 | 35.82 |
| Support Level | $3.46 | $0.68 |
| Resistance Level | $3.79 | $0.73 |
| Average True Range (ATR) | 0.18 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 51.98 | 2.13 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.